TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma
Clinical trial NCT01721941 · UNKNOWN
Trial details
- NCT number
- NCT01721941
- Sponsor
- Scripps Clinic Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.